Alomfilimab (Anti-ICOS / CD278)

Alomfilimab (Anti-ICOS / CD278) is a human immunoglobulin G1 (IgG1) kappa monoclonal antibody that recognizes inducible T-cell co-stimulator (ICOS; CD278), with potential immunomodulating and antineoplastic activities. MW: 146.5 kD.

• Supplier: Selleck Chemicals
• Product #: A2768
• Sku #: A2768-1mg